Epizyme reported $332.27M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Amarin AMRN:US $ 1035.8M 9.19M
Amgen AMGN:US $ 64993M 5220M
Avrobio Inc AVRO:US $ 216.45M 21.64M
Biogen BIIB:US $ 23806.7M 663.7M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Cerulean Pharma CERU:US $ 48.81M 33.99M
Daiichi Sankyo 4568:JP Y 2110729M 48259M
Eisai 4523:JP Y 1140111M 10770M
Epizyme EPZM:US $ 332.27M 20.28M
Exelixis EXEL:US $ 2447.74M 80.47M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Glaxosmithkline GSK:US $ 78689M 1678M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Novartis NOVN:VX SF 121209M 2806M
Novartis NVS:US $ 121209M 2806M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Spectrum Pharmaceuticals SPPI:US $ 147.8M 27.24M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Xencor XNCR:US $ 697.26M 1.66M